Live Breaking News & Updates on Division Of Lymphoma

Stay updated with breaking news from Division of lymphoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Phillips on the Safety and Efficacy of Glofitamab in Relapsed/Refractory MCL

Tycel Phillips, MD, MPH, discusses updated efficacy and safety data with glofitamab for the treatment of relapsed/refractory mantle cell lymphoma. ....

Tycel Phillips , Division Of Lymphoma , Department Of Hematology Hematopoietic Cell Transplantation , Hematopoietic Cell Transplantation ,

City of Hope's Dr Tycel Phillips Discusses Promise of Glofitamab in Heavily Pretreated MCL

Glofitamab is currently being investigated in a phase 1/2, multicenter, open-label, dose-escalation study as monotherapy and in combination with obinutuzumab, following 1-time fixed-dose pretreatment with obinutuzumab. ....

United States , Tycell Phillips , Department Of Hematology Hematopoietic Cell Transplantation , Division Of Lymphoma , American Society Of Clinical Oncology , American Society , Clinical Oncology , Hematopoietic Cell Transplantation , Chronic Lymphocytic Leukemia ,

Acalabrutinib Yields Long-Term Efficacy in a Pooled Analysis of Higher-Risk CLL

Treatment with acalabrutinib-based regimens led to long-term benefits in patients with higher-risk CLL, across all lines of therapy. ....

United States , Dana Farber Cancer Institute , Matthews Davids , Division Of Lymphoma , Harvard Medical School , Clinical Research , Dana Farber Cancer Institute , Precision Medicine In Oncology , Chronic Lymphocytic Leukemia ,

City of Hope Shares Promising Stem Cell and Blood Cancer Data at ASCO 2024

City of Hope Shares Promising Stem Cell and Blood Cancer Data at ASCO 2024
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United States , William Dale , Daniel Schmolze , Sumanta Kumar Pal , Tycel Phillips , Marwang Fakih , Richardt Lee , Tanyanika Phillips , Monzrm Al Malki , Cristiane Decat Bergerot , Department Of Supportive Care Medicine , Department Of Hematology Hematopoietic Cell Transplantation , Division Of Lymphoma , Integrative Medicine Program , Division Of Leukemia , Department Of Medical Oncology Therapeutics Research , Department Of Pathology , Gastrointestinal Cancer , Medical Oncology , Hematologic Malignancies , Myelodysplastic Syndromes , Hematopoietic Cell , Chronic Lymphocytic , Genitourinary Cancer , Patient Centered Care , Older Adults With ,

Dr Davids on Treatment With Pirtobrutinib in CLL/SLL With/Without Prior BCL-2 Inhibitor Exposure

Matthew S. Davids, MD, MMSc, discusses key efficacy results from 2 follow-up analyses of the phase 1/2 BRUIN trial evaluating pirtobrutinib. ....

Matthews Davids , Harvard Medical School , Division Of Lymphoma , Dana Farber Cancer Institute , Phase 1 2 Bruin Trial Nct03740529 , Irtobrutinib Jaypirca , Hematologic Malignancies , Richter Transformation ,